Form 4 Tracker
Gregory R Friberg

EVP, Chief R&D Officer · 2 filings · Latest: May 7, 2026

BIOMARIN PHARMACEUTICAL INC
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
BMRN
Gregory R FribergEVP, Chief R&D OfficerMay 7, 2026
Sale
$53.853,281$176.7K51,818
BMRN
Gregory R FribergEVP, Chief R&D OfficerMar 17, 2026
Tax Withholding
$56.051,629$91.3K55,099
BMRN
Gregory R FribergEVP, Chief R&D OfficerMar 16, 2026
Grant/Award
$0.0019,15056,728